naltrexone
FDA Approves Naldemedine for OIC in Adults With Chronic Noncancer Pain
Naldemedine is a peripherally acting mu-opioid antagonist designed to be taken once daily by adults with OIC. The ...
MARCH 24, 2017
FDA Approves Troxyca ER for Pain Management
Oxycodone-naltrexone ER has properties that are expected to reduce abuse when crushed and administered by the ...
SEPTEMBER 5, 2016
Load more